Distribution of HLA alleles and haplotypes in Jinuo and Wa populations in Southwest China

Autor: Shi, Li, Ogata, Saeko, Yu, Jian Kun, Ohashi, Jun, Yu, Liang, Shi, Lei, Sun, Hao, Lin, Keqin, Huang, Xiao Qin, Matsushita, Masaki, Horai, Satoshi, Muramatsu, Masaaki, Chu, Jia You, Tokunaga, Katsushi

Publikováno v: In Human Immunology 2008 69(1):58-65

Sentiment Feature Selection Algorithm for Chinese Micro-blog

Autor: Yu Jian Kun, Zhao Lei

Publikováno v: 2014 International Conference on Management of e-Commerce and e-Government.

Sentiment analysis is to extract the opinion of the user from of the text documents. Sentiment classification using machine learning methods face problem of handing huge number of unique terms in a feature vector for the classification. Therefore, a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::132b8f0751ce1e5c261b186b00c66e2b
https://doi.org/10.1109/icmecg.2014.32

Association Study between IL-10 Promoter Genetic Polymorphisms and Chronic HCV Infection in Yunnan Han Nationality. (English)

Autor: LI Ying, ZHANG Shu-qiong, YU Jian-kun, WANG Ya-ling, Yao Yu-feng, SHI Li

Publikováno v: Journal of Kunming Medical University / Kunming Yike Daxue Xuebao; 2015, Vol. 36 Issue 1, p15-18, 4p

Regulation of alternative splicing of Bcl-x by IL-6, GM-CSF and TPA.

Autor: LI, Chang You, CHU, Jia You, YU, Jian Kun, HUANG, Xiao Qin, LIU, Xiao Juan, SHI, Li, CHE, Yan Chun, XIE, Jiu Yong

Publikováno v: Cell Research; Dec2004, Vol. 14 Issue 6, p473-479, 7p

[Corrigendum) RNA interference‑mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin‑induced apoptosis dependent on JNK activation.

Autor: He M; Department of Pharmacology, China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China., Sun HG; Department of Pharmacology, China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China., Hao JY; Department of Pharmacology, China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China., Li YL; Department of Pharmacology, China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China., Yu JK; Department of Pharmacology, China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China., Yan YY; Department of Pharmacology, China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China., Zhao L; Department of Pharmacology, China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China., Li N; Department of Pharmacology, China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China., Wang Y; Department of Pharmacology, China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China., Bai XF; Department of Pharmacology, China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China., Yu ZJ; Department of Pharmacology, China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China., Zheng ZH; Institute of Pathology and Pathophysiology, China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China., Mi XY; Institute of Pathology and Pathophysiology, China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China., Wang EH; Institute of Pathology and Pathophysiology, China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China., Wei MJ; Department of Pharmacology, China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China.

Publikováno v: Oncology reports [Oncol Rep] 2022 Jun; Vol. 47 (6). Date of Electronic Publication: 2022 May 11.